Skip to main content

Table 3 Distribution of Genotypes for Furin Variable in Hypertensives and Normotensives

From: Associations between genetic variations in the FURIN gene and hypertension

Population

Variants

Genotypes

NT

HT

Additive model

χ2

P

   

n(%)

n(%)

OR(95%CI)

  
  

CC

315(65.6)

290(65.3)

   
  

CT

143(29.8)

134(30.2)

1.1 (0.87-1.391)

0.018

0.991*

 

-7315C > T

TT

22(4.8)

20(4.5)

  

0.424†

 

rs4932178

      
  

CC CT+TT

315(65.6)

290(65.3)

 

0.01

0.921*

   

165(34.6)

154 (34.7)

1.132 (0.853-1.503)

 

0.391†

  

GG

171(35.7)

145(30.27)

   
 

5604G > C

GC

239(49.9)

219(45.72)

1.084 (0.891-1.319)

2.286

0.319*

 

rs6226

CC

69(14.41)

79(16.49)

  

0.42†

Kazakh Chinese

 

CG CG+GG

171(35.7)

145(30.27)

1.031 (0.776-1.369)

0.9

0.343*

   

308(50.1)

298(46.76)

  

0.834†

  

CC

362(74.9)

322(72)

   
 

6262C > T

CT

113(23.4)

113(25.3)

1.284 (0.981-1.681)

1.748

0.417*

 

rs6227

TT

8(1.7)

12(2.7)

  

0.69†

  

CT vs CT+TT

362(74.9)

322(72)

1.28 (0.945-1.733)

1.012

0.313*

   

121(25.1)

125(28)

  

0.111†

  

CC

369(76.4)

310(45.7)

   
 

1970C > G

CG

106(21.9)

121(27.4)

1.451 (1.106-1.905)

4.784

0.091*

 

rs2071410

GG

8(1.7)

11(2.5)

  

0.008†

  

CG vs CG+GG

369(76.4)

310(45.7)

1.496 (1.103-2.028)

4.636

0.031*

   

114(22.6)

132(29.9)

  

0.01†

  

CC

322(67.9)

472(63.4)

   

Replication (Uygur Chinese)

1970C > G

CG

140(29.5)

234(31.4)

1.327 (1.07-1.646)

6.323

0.042*

 

rs2071410

GG

12(2.5)

39(5.2)

  

0.01†

  

CG vs CG+GG

322(67.9)

472(63.4)

1.307 (1.015-1.681)

2.672

0.102*

   

160(32)

273(36.6)

  

0.038†

  1. NT, normotensives; HT, hypertensives. In the additive model, odds ratios (ORs) were expressed per difference in number of minor alleles. In the dominant model, ORs were shown as heterozygotes and minor allele homozygotes compared with major allele homozygotes.*P was caculated by χ2 test; †P and ORs were caculated by mutivariable logistic regression analysis after adjustment for gender, age and present ills(dibetes mellitus and dyslipidemia)